Bifidobacterium animalis B94 significantly reduced the elevated levels of ALT and AST induced by D-galactosamine, improved the gut microbiota as well as metabolic dysbiosis, reduced pathological abnormalities in liver and intestinal tissues, and has important potential applications for liver injury and liver failure. The gene discussed is GPT; the disease is Hepatic failure.